{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Gingerol", "Hepatic fibrosis", "Nuclear factor \u03baB", "Toll-like receptor 4"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26809353", "DateCompleted": {"Year": "2016", "Month": "12", "Day": "13"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "01", "Day": "26"}], "ELocationID": ["10.1007/s00210-016-1210-1"], "Language": ["eng"], "Journal": {"ISSN": "1432-1912", "JournalIssue": {"Volume": "389", "Issue": "4", "PubDate": {"Year": "2016", "Month": "Apr"}}, "Title": "Naunyn-Schmiedeberg's archives of pharmacology", "ISOAbbreviation": "Naunyn Schmiedebergs Arch Pharmacol"}, "ArticleTitle": "Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators.", "Pagination": {"StartPage": "419", "EndPage": "428", "MedlinePgn": "419-28"}, "Abstract": {"AbstractText": ["6-Gingerol (Gin) is known to possess hepatoprotective effects. Liver fibrosis is a major health concern that results in significant morbidity and mortality. There is no FDA-approved medication for liver fibrosis. The present work aimed at exploring the beneficial effects of Gin against liver fibrosis in rats. Experimental fibrosis was induced by challenging animals with CCl4 for 6\u00a0weeks. Gin significantly ameliorated the increase in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, albumin, total cholesterol (TC) and triglyceride (TG) concentrations, and liver index. These effects were confirmed by light and electron microscopic examinations. The antifibrotic effects were confirmed by examining Masson trichrome-stained liver sections which indicated reduced collagen deposition in Gin-treated animals. Further, Gin administration hampered alpha-smooth muscle actin (\u03b1-SMA) expression and significantly reduced hepatic content of transforming growth factor-beta (TGF-\u03b2). Also, Gin elicited profound antioxidant actions as indicated by preventing reduced glutathione (GSH) depletion and lipid peroxide accumulation. The observed antifibrotic activities involved decreased production of nuclear factor \u03baB (NF-\u03baB), tumor necrosis factor alpha (TNF-\u03b1), expression of toll-like receptor 4 (TLR4), intercellular adhesion molecule (ICAM), and vascular cell adhesion molecule (VCAM). Involvement of Gin anti-inflammatory activity was verified by the decreased expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in livers of animals treated with Gin. Thus, it can be concluded that Gin protects against CCl4-induced liver fibrosis in rats. This can be ascribed, at least partly, to its antioxidant, anti-inflammatory effects as well as the inhibition of NF-\u03baB/TLR-4 expression."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Group, Deanship of Scientific Research, King Abdulaziz University, Jeddah, 21589, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia."}], "LastName": "Algandaby", "ForeName": "Mardi M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Group, Deanship of Scientific Research, King Abdulaziz University, Jeddah, 21589, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt."}], "LastName": "El-Halawany", "ForeName": "Ali M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Group, Deanship of Scientific Research, King Abdulaziz University, Jeddah, 21589, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt."}], "LastName": "Abdallah", "ForeName": "Hossam M", "Initials": "HM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia."}], "LastName": "Alahdal", "ForeName": "Abdulrahman M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Tanta University, Tanta, Egypt."}], "LastName": "Nagy", "ForeName": "Ayman A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, P.O. Box 80260, 21589, Saudi Arabia."}], "LastName": "Ashour", "ForeName": "Osama M", "Initials": "OM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Group, Deanship of Scientific Research, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. aaabdulalrahman1@kau.edu.sa."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, P.O. Box 80260, 21589, Saudi Arabia. aaabdulalrahman1@kau.edu.sa."}], "LastName": "Abdel-Naim", "ForeName": "Ashraf B", "Initials": "AB"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Naunyn Schmiedebergs Arch Pharmacol", "NlmUniqueID": "0326264", "ISSNLinking": "0028-1298"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Catechols"}, {"RegistryNumber": "0", "NameOfSubstance": "Fatty Alcohols"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Tlr4 protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptor 4"}, {"RegistryNumber": "925QK2Z900", "NameOfSubstance": "gingerol"}, {"RegistryNumber": "CL2T97X0V0", "NameOfSubstance": "Carbon Tetrachloride"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["blood"], "DescriptorName": "Biomarkers"}, {"QualifierName": [], "DescriptorName": "Carbon Tetrachloride"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Catechols"}, {"QualifierName": ["etiology", "metabolism", "pathology", "prevention & control"], "DescriptorName": "Chemical and Drug Induced Liver Injury"}, {"QualifierName": [], "DescriptorName": "Cytoprotection"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Fatty Alcohols"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": ["drug effects"], "DescriptorName": "Lipid Peroxidation"}, {"QualifierName": ["drug effects", "metabolism", "ultrastructure"], "DescriptorName": "Liver"}, {"QualifierName": ["chemically induced", "metabolism", "pathology", "prevention & control"], "DescriptorName": "Liver Cirrhosis, Experimental"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["antagonists & inhibitors", "genetics", "metabolism"], "DescriptorName": "Toll-Like Receptor 4"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Z Naturforsch C. 2001 Jul-Aug;56(7-8):649-59", "ArticleIdList": ["11531102"]}, {"Citation": "Innate Immun. 2012 Oct;18(5):700-8", "ArticleIdList": ["22330637"]}, {"Citation": "Gastroenterol Res Pract. 2010;2010:240365", "ArticleIdList": ["21197425"]}, {"Citation": "Bioorg Med Chem Lett. 2009 Jul 15;19(14):3909-11", "ArticleIdList": ["19362472"]}, {"Citation": "Pharmacol Toxicol. 1998 Dec;83(6):231-9", "ArticleIdList": ["9868740"]}, {"Citation": "Zhong Xi Yi Jie He Xue Bao. 2011 Nov;9(11):1264-9", "ArticleIdList": ["22088594"]}, {"Citation": "Biosci Biotechnol Biochem. 2009 Jul;73(7):1474-8", "ArticleIdList": ["19584560"]}, {"Citation": "Front Biosci. 2002 Apr 01;7:d808-26", "ArticleIdList": ["11897564"]}, {"Citation": "Front Biosci. 2002 May 01;7:a99-108", "ArticleIdList": ["11994208"]}, {"Citation": "Food Chem Toxicol. 2011 Jun;49(6):1261-9", "ArticleIdList": ["21396424"]}, {"Citation": "Br J Pharmacol. 2012 Sep;167(1):128-40", "ArticleIdList": ["22489648"]}, {"Citation": "J Environ Pathol Toxicol Oncol. 2015;34(1):11-21", "ArticleIdList": ["25746828"]}, {"Citation": "Cytotechnology. 2015 Aug;67(4):641-52", "ArticleIdList": ["24794903"]}, {"Citation": "Evid Based Complement Alternat Med. 2013;2013:146142", "ArticleIdList": ["23843863"]}, {"Citation": "Anal Biochem. 1978 May;86(1):271-8", "ArticleIdList": ["655387"]}, {"Citation": "Phytother Res. 2015 Apr;29(4):566-72", "ArticleIdList": ["25631463"]}, {"Citation": "Biofactors. 2010 May-Jun;36(3):169-78", "ArticleIdList": ["20232343"]}, {"Citation": "Histol Histopathol. 2010 Aug;25(8):1075-91", "ArticleIdList": ["20552556"]}, {"Citation": "Hepatology. 2000 Jan;31(1):109-16", "ArticleIdList": ["10613735"]}, {"Citation": "N Engl J Med. 1993 Jun 24;328(25):1828-35", "ArticleIdList": ["8502273"]}, {"Citation": "J Clin Invest. 2005 Feb;115(2):209-18", "ArticleIdList": ["15690074"]}, {"Citation": "Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):459-72", "ArticleIdList": ["20678019"]}, {"Citation": "Biofactors. 2006;26(3):189-200", "ArticleIdList": ["16971750"]}, {"Citation": "Mol Cells. 2009 Feb 28;27(2):211-5", "ArticleIdList": ["19277504"]}, {"Citation": "Biochem Biophys Res Commun. 2012 Mar 23;419(4):735-40", "ArticleIdList": ["22387540"]}, {"Citation": "Nutrients. 2015 Feb 04;7(2):999-1020", "ArticleIdList": ["25658238"]}, {"Citation": "Compr Physiol. 2013 Oct;3(4):1473-92", "ArticleIdList": ["24265236"]}, {"Citation": "Free Radic Res. 2007 May;41(5):603-14", "ArticleIdList": ["17454143"]}, {"Citation": "J Surg Res. 2007 Apr;138(2):209-13", "ArticleIdList": ["17291534"]}, {"Citation": "Antimicrob Agents Chemother. 2014;58(4):1872-8", "ArticleIdList": ["24395230"]}, {"Citation": "Nat Rev Immunol. 2004 Jul;4(7):499-511", "ArticleIdList": ["15229469"]}, {"Citation": "Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L497-504", "ArticleIdList": ["18586954"]}, {"Citation": "J Pharm Pharmacol. 1995 Apr;47(4):329-32", "ArticleIdList": ["7791032"]}, {"Citation": "Hepatology. 2006 Feb;43(2 Suppl 1):S54-62", "ArticleIdList": ["16447271"]}, {"Citation": "Curr Med Chem. 2012;19(28):4850-60", "ArticleIdList": ["22709007"]}, {"Citation": "J Pharm Pharm Sci. 2013;16(2):304-12", "ArticleIdList": ["23958199"]}, {"Citation": "Hepatology. 2009 Oct;50(4):1294-306", "ArticleIdList": ["19711424"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "9", "Day": "13"}, {"Year": "2016", "Month": "1", "Day": "11"}, {"Year": "2016", "Month": "1", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "1", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26809353", "10.1007/s00210-016-1210-1", "10.1007/s00210-016-1210-1"]}}], "PubmedBookArticle": []}